Aptevo Therapeutics's total assets for Q3 2025 were $27.00M, an increase of 72.79% from the previous quarter. APVO total liabilities were $9.60M for the fiscal quarter, a 5.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.